[PRIVATE] University of Virginia School of Medicine and School of Nursing

Event

2022 60th Annual Swineford Allergy Conference

presented by [PRIVATE] University of Virginia School of Medicine and School of Nursing

11 others would like to attend.

Register Now

Notification icon Friday, April 8, 2022 8 AM - Saturday, April 9, 2022 12 PM America/New_York

Location Icon 1307 Lane Rd, Charlottesville, VA 22903, United States

Event info

OVERVIEW

  • Immune responses to allergens
  • Relevance of Mast Cell TGFbeta to Fibrosis in the Esophageal Wall
  • The Future of Rhinitis Treatment
  • Immunocompromised Patients and the COVID-19 Vaccine
  • T Cells and the Allergic Response to Food
  • The Next Generation of Inner City Asthma

TARGET AUDIENCE

Physicians, Lab Techs in Immunology, Researchers

LEARNING OBJECTIVES

The field of Allergy and Immunology continues to develop and change both clinically and scientifically. The Swineford Allergy Conference is dedicated to educating physicians involved in treat¬ing patients with disorders of allergic, pulmonary, or immunologic origin.

At the completion of the 60th Swineford Allergy conference, the participant should be able to understand and appreciate:

  • the role immune responses play in allergens
  • the relevance of mast cells TGF-beta to fibrosis in the esophageal wall
  • the options for the future treatment of rhinitis
  • the role of T cells on allergic responses to food
  • how the future of asthma is changing for urban patients
  • the meaning of immunocompromised in the time of COVID-19 pandemic

ACCREDITATION

The University of Virginia School of Medicine and School of Nursing designates this live
activity for a maximum of
9.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.

Faculty
  • Tom Platts-Mills

    Course Director

Course Syllabus

Click HERE to view the syllabus

11 others would like to attend.

Register Now


0 Comments
Login to view comments. Click here to Login